newsfilter
← Latest News
GlobeNewswire·

Selecta Biosciences to Participate at the LifeSci Partners 11th Annual Corporate Access Event

WATERTOWN, Mass., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune respo